Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Lymphology ; 53(3): 136-140, 2020.
Article in English | MEDLINE | ID: mdl-33350287

ABSTRACT

Detailed imaging of the lymphatic system often requires direct injection of contrast into lymph nodes which can be technically challenging, time consuming, and produce painful stimuli. We sought to describe the use of non-contrast MR lymphography (NCMRL) for normal controls and patients with a variety of rare disorders associated with lymphatic pathologies. Two control subjects and five affected patients (decompensated Fontan circulation, central conducting lymphatic abnormality, familial lymphedema and two with Gorham-Stout disease) were studied. NCMRL images were segmented in a semiautomated fashion and the major lymphatic channels and thoracic duct (TD) highlighted for identification. Adequate imaging was available for both controls and 4/5 affected patients; the youngest patient could not be imaged given patient motion. For the two controls, the TD was seen in the expected anatomic location. For the decompensated Fontan patient, there were numerous tortuous lymphatic channels, predominantly in the upper chest and neck. For the familial lymphedema patient, a TD was not identified; instead, peripheral lymphatic collaterals near the lateral chest walls. For the first Gorham- Stout patient, the TD was enlarged with large intrathoracic lymph collections. For the second Gorham-Stout patient, there were bilateral TD with lymph collections in vertebral bodies. Using NCMRL, we were able to image normal and abnormal lymphatic systems. An important learning point is the potential need for sedation for younger patients due to long image acquisition times and fine resolution of the structures of interest.


Subject(s)
Lymphatic Abnormalities/diagnostic imaging , Lymphography/methods , Magnetic Resonance Imaging/methods , Case-Control Studies , Humans , Lymphatic Vessels/abnormalities , Lymphatic Vessels/diagnostic imaging , Osteolysis, Essential/diagnosis , Rare Diseases , Thoracic Duct/abnormalities
2.
Lymphology ; 52(4): 157-165, 2019.
Article in English | MEDLINE | ID: mdl-32171182

ABSTRACT

The number of patients surviving repair of complex congenital heart disease (CCHD) has increased due to improved surgical techniques, post operative management and outpatient care. Likewise, this growing patient population has demonstrated an increasing number and complexity of complications involving the lymphatic system. To evaluate the peripheral and central lymphatic system, whole-body lymphangioscintigraphy (LAS) is considered as the initial imaging evaluation of choice. To date, very few publications exist on the value of lymphatic imaging techniques in infants and small children with lymphatic complications following surgery for congenital heart disease. A retrospective review of medical records from 2008 to 2018 was performed for pediatric patients referred for lymphatic complications after CCHD surgery at an academic medical center. LAS and SPECT/CT was performed using intradermal bipedal injections of Tc 99m labeled filtered sulfur colloid, and in some patients also bilateral hand injections, followed by dynamic imaging and whole- body planar imaging typically up to 180 minutes post injection. Clinical decision making and outcomes were recorded. LAS and SPECT/CT were performed without complication in pediatric patients with prior surgery for CCHD. LAS successfully localized various lymphatic abnormalities such as lymphatic obstruction, reflux, and leaks, which were further delineated by SPECT/CT. LAS findings directed further evaluation with more definitive studies, management and prognosis. Five of the ten patients had follow up outcome data - 2 years and up to 10 years. LAS and SPECT/CT are safe and effective techniques for the initial evaluation of lymphatic abnormalities in pediatric patients with CCHD. LAS, particularly with further 3D localization by SPECT/CT, provides functional imaging of peripheral and central lymphatic flow and thus provides guidance for medical therapy, non operative interventional management, and surgical therapy for these diverse, debilitating, and often life threatening disorders.


Subject(s)
Heart Defects, Congenital/complications , Lymphatic Diseases/diagnosis , Lymphatic Diseases/etiology , Lymphoscintigraphy , Postoperative Complications/diagnosis , Single Photon Emission Computed Tomography Computed Tomography , Whole Body Imaging , Child , Child, Preschool , Female , Heart Defects, Congenital/diagnosis , Heart Defects, Congenital/surgery , Humans , Infant , Lymphoscintigraphy/methods , Male , Retrospective Studies , Single Photon Emission Computed Tomography Computed Tomography/methods , Whole Body Imaging/methods
3.
Lymphology ; 51(1): 18-27, 2018.
Article in English | MEDLINE | ID: mdl-30248728

ABSTRACT

Gorham-Stout disease - also known as "disappearing bone disease" is currently considered a single entity with varying clinical manifestations. We reviewed the existent literature from the earliest historic description(Jackson in 1838) and Gorham and Stout's original series of patients, multiple case reports and series since. After analyzing 212 reported cases, we identified 76 cases with details that recorded either a history of multifocal disease or an identifiable history of preceding trauma. From this review, we have defined two distinct Gorham-Stout entities - those characteristically associated with lymphangiomatosis [a form of GLA (generalized lymphangiomatosis) questionably distinguishable by bone biopsy and radiologic appearance] with multifocal distributed bone lesions, and those others, usually self-limited, first appearing after a traumatic event and always confined to a single bone or closely adjacent one. Multifocal disease is more likely to have chylothorax as a complication. These two Gorham-Stout entities differ in their demographic distribution, clinical history and manifestations, and they follow divergent clinical courses. The prognosis differs, and so should approaches to monitoring as well as acute and long-term treatment. Further research should seek to identify and define the differences in pathology and molecular mechanisms.


Subject(s)
Chylothorax/pathology , Contusions/pathology , Fractures, Bone/pathology , Lymphangioma/pathology , Osteolysis, Essential/pathology , Adolescent , Adult , Aged , Bone and Bones/pathology , Child , Child, Preschool , Chylothorax/diagnosis , Chylothorax/etiology , Chylothorax/surgery , Contusions/complications , Contusions/diagnosis , Disease Management , Female , Fractures, Bone/complications , Fractures, Bone/diagnosis , Humans , Infant , Lymphangioma/complications , Lymphangioma/diagnosis , Male , Middle Aged , Osteolysis, Essential/diagnosis , Osteolysis, Essential/etiology , Osteolysis, Essential/surgery , Prognosis , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...